253 related articles for article (PubMed ID: 9352126)
21. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests.
Trinchet JC; Hartmann DJ; Pateron D; Laarif M; Callard P; Ville G; Beaugrand M
J Hepatol; 1991 Mar; 12(2):139-44. PubMed ID: 1711064
[TBL] [Abstract][Full Text] [Related]
22. Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon-alpha.
Teran JC; Mullen KD; Hoofnagle JH; McCullough AJ
Hepatology; 1994 Apr; 19(4):849-56. PubMed ID: 8138256
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis.
Guéchot J; Laudat A; Loria A; Serfaty L; Poupon R; Giboudeau J
Clin Chem; 1996 Apr; 42(4):558-63. PubMed ID: 8605673
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of serum procollagen aminoterminal propeptide III, laminin, and hydroxyproline as predictors of severe fibrosis in patients with chronic hepatitis C.
Attallah AM; Toson EA; Shiha GE; Omran MM; Abdel-Aziz MM; El-Dosoky I
J Immunoassay Immunochem; 2007; 28(3):199-211. PubMed ID: 17613667
[TBL] [Abstract][Full Text] [Related]
25. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
[TBL] [Abstract][Full Text] [Related]
26. Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease.
Nouchi T; Worner TM; Sato S; Lieber CS
Alcohol Clin Exp Res; 1987 Jun; 11(3):287-91. PubMed ID: 3307495
[TBL] [Abstract][Full Text] [Related]
27. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
[TBL] [Abstract][Full Text] [Related]
28. The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.
Valva P; Casciato P; Diaz Carrasco JM; Gadano A; Galdame O; Galoppo MC; Mullen E; De Matteo E; Preciado MV
PLoS One; 2011; 6(8):e23218. PubMed ID: 21858035
[TBL] [Abstract][Full Text] [Related]
29. Serum procollagen III N-terminal peptide and laminin P1 fragment concentrations in alcoholic liver disease and primary biliary cirrhosis.
van Zanten RA; van Leeuwen RE; Wilson JH
Clin Chim Acta; 1988 Oct; 177(2):141-6. PubMed ID: 3233763
[TBL] [Abstract][Full Text] [Related]
30. [Correlation of serum markers with fibrosis staging in chronic viral hepatitis].
Wang T; Wang B; Liu X
Zhonghua Bing Li Xue Za Zhi; 1998 Jun; 27(3):185-90. PubMed ID: 11244978
[TBL] [Abstract][Full Text] [Related]
31. Biochemical markers of hepatic fibrosis.
Plebani M; Burlina A
Clin Biochem; 1991 Jun; 24(3):219-39. PubMed ID: 1651819
[TBL] [Abstract][Full Text] [Related]
32. Procollagen III peptide and fibronectin in alcohol-related chronic liver disease: correlations with morphological features and biochemical tests.
Gabrielli GB; Faccioli G; Casaril M; Capra F; Bonazzi L; Falezza G; Tomba A; Baracchino F; Corrocher R
Clin Chim Acta; 1989 Feb; 179(3):315-22. PubMed ID: 2714004
[TBL] [Abstract][Full Text] [Related]
33. Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis.
Castera L; Hartmann DJ; Chapel F; Guettier C; Mall F; Lons T; Richardet JP; Grimbert S; Morassi O; Beaugrand M; Trinchet JC
J Hepatol; 2000 Mar; 32(3):412-8. PubMed ID: 10735610
[TBL] [Abstract][Full Text] [Related]
34. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis.
Zheng M; Cai WM; Weng HL; Liu RH
World J Gastroenterol; 2002 Dec; 8(6):1073-6. PubMed ID: 12439928
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of non-invasive serum markers for predicting liver fibrosis in Egyptian patients with chronic HCV infection.
El Guesiry D; Moez P; Hossam N; Kassem M
Egypt J Immunol; 2011; 18(2):1-12. PubMed ID: 23082465
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic accuracy of enhanced liver fibrosis test to assess liver fibrosis in patients with chronic hepatitis C.
Catanzaro R; Milazzo M; Arona S; Sapienza C; Vasta D; Arcoria D; Marotta F
Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):500-7. PubMed ID: 24103280
[TBL] [Abstract][Full Text] [Related]
37. [Serum variations of 2 markers of fibrogenesis in chronic hepatitis C treated with alpha interferon].
Soresi M; Bascone F; Agate V; Carroccio A; Barresi E; Cartabellotta A; Aragona F; Montalto G
Recenti Prog Med; 1997 Feb; 88(2):73-6. PubMed ID: 9148370
[TBL] [Abstract][Full Text] [Related]
38. Laminin and procollagen-III-peptide as a serum marker for hepatic fibrosis in congenital biliary atresia.
Sasaki F; Hata Y; Hamada H; Takahashi H; Uchino J
J Pediatr Surg; 1992 Jun; 27(6):700-3. PubMed ID: 1501026
[TBL] [Abstract][Full Text] [Related]
39. Comparison of assays for N-amino terminal propeptide of type III procollagen in chronic hepatitis C by using receiver operating characteristic analysis.
Walsh KM; Fletcher A; MacSween RN; Morris AJ
Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):827-31. PubMed ID: 10514112
[TBL] [Abstract][Full Text] [Related]
40. Estimation of the production rates of serum aminoterminal propeptide of type III procollagen and laminin in human fibrotic liver.
Gressner AM; Kropf J; Tittor W
J Clin Chem Clin Biochem; 1987 Sep; 25(9):553-9. PubMed ID: 3681195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
